CLOSE
Relax, we can help.
With so many features and functions, we fully understand that getting the software to do what you want can be daunting at times.
YIKES!
CHANGES SAVED
SESSION EXPIRED
We appreciate that your browser hung out with us for so long, but your session has expired! If you want to register, we need to refresh your connection. We limit session time to 30 minutes for your security and to free up unused registration slots for others.
SESSION EXPIRED
Your session on this page has expired. We expire your session to protect your information in case you sit on a page too long with no activity.
CREATE ACCOUNT
ACCOUNT TYPE:
Please enter your access code!
CREATE ACCOUNT
ACCOUNT TYPE:
CONTACT HOST
Primary Contact:
Heather Newton
Email | Alt Email | 5126195534

 
SHARE
Overview
Agenda
Speakers
CME
Registration Fees
Supporters
Accommodations
Transportation/Parki
Abstracts
Support Opportunitie
Documents
Sponsors
Register ▸
THIS EVENT IS 100% FREE!

Dear Friends and Colleagues,

It gives us great pleasure to invite you to attend the 12th International Congress on Myeloproliferative Neoplasms, to be held on October 24-25, 2019 in New York City.

Since the inaugural Congress in 2001, this meeting has become the premier forum for discussion on the latest advances in myeloproliferative neoplasms (MPNs). This year, the Congress will focus on timely topics of interest to hematologists and oncologists who treat patients with these rare disorders.

The Congress program format will utilize case presentations to highlight the essential features of MPN pathophysiology, diagnosis and management, as well as the roles of next generation sequencing and the MPN driver mutation and allele burden in clinical decision making. In addition to defining the role of pegylated interferon and its long-acting derivatives in MPN therapy, the role of immunotherapy in the MPNs and novel agents for MPN treatment will be reviewed

New this year will be a discussion of the management of accelerated and blast phase MPN, patient selection for bone marrow transplantation, and how to integrate MPN patient symptom scores with therapeutic planning.

Congress attendees will have the opportunity to participate in a variety of educational formats including didactic sessions, case reviews, poster sessions and oral abstract presentations, as well as multiple networking and one-on-one discussion opportunities. To allow more time for participant questions, time has also been allotted for a panel discussion with Congress faculty.

We look forward to welcoming you to New York City in October!

Warm regards,

Richard T. Silver, MD

Weill Cornell Medicine

New York, New York, USA

Chairman, 12th Intl Congress on Myeloproliferative Neoplasms


Jerry L. Spivak, MD

Johns Hopkins University School of Medicine

Baltimore, Maryland, USA

Co-Chairman, 12th Intl Congress on Myeloproliferative Neoplasms


The Westin New York at Times Square
Address
The Westin New York Times Square
270 West 43rd Street
New York City, NY  USA
Selection Options
US Dollar
 
registration fee
Physician
Physician
$ 499.00 

Registration fees include conference materials, admittance to all scientific sessions, processing of certificates of attendance or continuing medical education, and all event meals and functions as specified in the agenda.

 
PA / Nurse / Fellow / Resident / Other
PA / Nurse / Fellow / Resident / Other
$ 299.00 

Registration fees include conference materials, admittance to all scientific sessions, processing of certificates of attendance or continuing medical education, and all event meals and functions as specified in the agenda.

 
Exhibitor/Industry
Exhibitor/Industry
$ 549.00 

Registration fees include conference materials, admittance to all scientific sessions, processing of certificates of attendance or continuing medical education, and all event meals and functions as specified in the agenda.

 
 
sessions
Continental Breakfast (I)
Continental Breakfast (I)
 
Thursday Oct 24, 2019 @  07:30:AM  —  08:30:AM EDT


 
General Session I
General Session I
 
Thursday Oct 24, 2019 @  08:30:AM  —  10:10:AM EDT
  • Welcome and Introduction
  • Hypoxia, Erythropoiesis and High Altitude Evolution
  • How Does Hematopoiesis in the MPNs Differ from Normal?
  • JAK2V617F - Interpreting the Variant Allele Fraction
 
General Session II
General Session II
 
Thursday Oct 24, 2019 @  10:35:AM  —  12:05:PM EDT
  • Hypereosinophilia
  • Case Presentations: Mastocytosis
  • Update on Pediatric MPNs
 
Lunch Session
Lunch Session
 
Thursday Oct 24, 2019 @  12:15:PM  —  01:15:PM EDT


 
General Session III
General Session III
 
Thursday Oct 24, 2019 @  01:25:PM  —  03:25:PM EDT
  • Essential Thrombocytosis: Tales from the Clinic
  • The Therapeutic Options for Treating MPNs are Finally Expanding
  • Arguments for Early Treatments of MPN
  • Update on the Status of Long Acting Interferons
 
General Session IV
General Session IV
 
Thursday Oct 24, 2019 @  03:50:PM  —  05:20:PM EDT
  • Novel Agents of Significant Clinical Interest in the MPNs
  • CMML in the Precision Medicine Era
  • Abstarct Presentations & Discussions
 
Welcome Reception and Poster Presentations
Welcome Reception and Poster Presentations
 
Thursday Oct 24, 2019 @  05:30:PM  —  07:00:PM EDT


 
Continental Breakfast (II)
Continental Breakfast (II)
 
Friday Oct 25, 2019 @  07:15:AM  —  08:15:AM EDT


 
General Session V
General Session V
 
Friday Oct 25, 2019 @  08:30:AM  —  10:30:AM EDT
  • CML in 2019: An Update
  • Treatment of Both Blast and Accelerated Phase Disease of the MPNs: An Update
  • Patient Selection and Results of Stem Cell Transplantation for Patients with Myelofibrosis


 
General Session VI
General Session VI
 
Friday Oct 25, 2019 @  11:00:AM  —  01:05:PM EDT
  • How I Treat MPN-Related Symptom Burden
  • Panel Discussion - Questions from the Audience
  • Closing Remarks
 
REGISTER NOW
POWERED BY